Hubei KTLC

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 11, 2023	Neurophth Therapeutics	$95.0M Series C	Hubei KTLC, Wuhan, Wuhan Hi-Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River-CMB International Industry Fund	CMG-SDIC Capital, Silicon Paradise Asset Management, Yangtze River Industry Fund

Total Raised

N/A

Valuation

N/A